IN2012DN03387A - - Google Patents
Info
- Publication number
- IN2012DN03387A IN2012DN03387A IN3387DEN2012A IN2012DN03387A IN 2012DN03387 A IN2012DN03387 A IN 2012DN03387A IN 3387DEN2012 A IN3387DEN2012 A IN 3387DEN2012A IN 2012DN03387 A IN2012DN03387 A IN 2012DN03387A
- Authority
- IN
- India
- Prior art keywords
- naphtalen
- hydroxycarbamoyl
- benzamide
- hydroxy
- histone deacetylase
- Prior art date
Links
- 229940121372 histone deacetylase inhibitor Drugs 0.000 abstract 2
- 239000003276 histone deacetylase inhibitor Substances 0.000 abstract 2
- XIZXADDGOCJZAL-UHFFFAOYSA-N 3h-dioxole-5-carboxylic acid Chemical compound OC(=O)C1=CCOO1 XIZXADDGOCJZAL-UHFFFAOYSA-N 0.000 abstract 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 abstract 1
- VDEUYMSGMPQMIK-UHFFFAOYSA-N benzhydroxamic acid Chemical compound ONC(=O)C1=CC=CC=C1 VDEUYMSGMPQMIK-UHFFFAOYSA-N 0.000 abstract 1
- 125000005605 benzo group Chemical group 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2009A001837A IT1396915B1 (it) | 2009-10-23 | 2009-10-23 | Dietil-[6-(4-idrossicarbamoil-fenil-carbamoilossimetil)-naftalen-2-il-metil]-ammonio cloruro ed altri derivati della n-idrossi-benzammide per l'uso nel trattamento di infezioni da hiv. |
| PCT/IB2010/054139 WO2011048514A1 (en) | 2009-10-23 | 2010-09-14 | Derivatives of n-hydroxybenzamide for treating hiv infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN03387A true IN2012DN03387A (enExample) | 2015-10-23 |
Family
ID=42153811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3387DEN2012 IN2012DN03387A (enExample) | 2009-10-23 | 2010-09-14 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8637702B2 (enExample) |
| EP (1) | EP2490682A1 (enExample) |
| JP (1) | JP5746196B2 (enExample) |
| KR (1) | KR101687644B1 (enExample) |
| CN (1) | CN102548551A (enExample) |
| BR (1) | BR112012008780A2 (enExample) |
| CA (1) | CA2773210C (enExample) |
| IN (1) | IN2012DN03387A (enExample) |
| IT (1) | IT1396915B1 (enExample) |
| WO (1) | WO2011048514A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6272773B2 (ja) * | 2011-11-29 | 2018-01-31 | ナンジン アルゲン ファルマ カンパニー リミテッドＮａｎｊｉｎｇ Ａｌｌｇｅｎ Ｐｈａｒｍａ Ｃｏ． Ｌｔｄ． | Ｈｄａｃ６阻害剤・抗腫瘍剤用複素環アミド化合物 |
| CN104093403A (zh) | 2012-02-03 | 2014-10-08 | 意大发马克股份公司 | 用于治疗肌肉萎缩症的二乙基-[6-(4-羟基氨基甲酰基-苯基-氨基甲酰氧基-甲基)-萘-2-基-甲基]-氯化铵 |
| IT201600074606A1 (it) * | 2016-07-18 | 2018-01-18 | Italfarmaco Spa | New benzo-N-hydroxy amide compounds having antitumor activity |
| EP3525821A4 (en) | 2016-10-17 | 2020-09-09 | University of Maryland | MULTI-SPECIFIC ANTIBODIES TARGETING THE HUMAN IMMUNODEFICIENCY VIRUS AND THEIR METHODS OF USE |
| IT201900003281A1 (it) * | 2019-03-06 | 2020-09-06 | Chemi Spa | Processo per preparare {6-[(dietilammino)metil]naftalen-2-il}metil [4-(idrossicarbamoil)fenil]carbammato ad elevata purezza |
| WO2022088047A1 (zh) * | 2020-10-30 | 2022-05-05 | 中国科学院深圳先进技术研究院 | Itf2357在制备预防和治疗冠状病毒的药物中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1283637B1 (it) | 1996-05-14 | 1998-04-23 | Italfarmaco Spa | Composti ad attivita' antinfiammatoria ed immunosoppressiva |
| ITMI20030025A1 (it) | 2003-01-10 | 2004-07-11 | Italfarmaco Spa | Derivati dell'acido idrossammico ad attivita' antinfiammatoria. |
| ITMI20030063A1 (it) | 2003-01-17 | 2004-07-18 | Italfarmaco Spa | Cloridrato monoidrato dell'estere (6-dietilamminometil-naftalen-2-il)metilico dell'acido (4-idrossicarbammoil-fenil)carbammico. |
| CN1960631A (zh) * | 2004-03-18 | 2007-05-09 | 萨马利坦制药有限公司 | 苯甲酰胺和苯甲酸酯抗hiv化合物 |
| ITMI20041347A1 (it) * | 2004-07-05 | 2004-10-05 | Italfarmaco Spa | Derivati di alfa-amminoacidi ad attivita'antiinfiammatoria |
| WO2008097654A1 (en) | 2007-02-08 | 2008-08-14 | Merck & Co., Inc. | Methods of using saha for treating hiv infection |
-
2009
- 2009-10-23 IT ITMI2009A001837A patent/IT1396915B1/it active
-
2010
- 2010-09-14 CN CN2010800454818A patent/CN102548551A/zh active Pending
- 2010-09-14 JP JP2012534798A patent/JP5746196B2/ja not_active Expired - Fee Related
- 2010-09-14 EP EP10771187A patent/EP2490682A1/en not_active Withdrawn
- 2010-09-14 IN IN3387DEN2012 patent/IN2012DN03387A/en unknown
- 2010-09-14 BR BR112012008780-0A patent/BR112012008780A2/pt not_active Application Discontinuation
- 2010-09-14 CA CA2773210A patent/CA2773210C/en not_active Expired - Fee Related
- 2010-09-14 KR KR1020127007623A patent/KR101687644B1/ko not_active Expired - Fee Related
- 2010-09-14 WO PCT/IB2010/054139 patent/WO2011048514A1/en not_active Ceased
- 2010-09-14 US US13/393,863 patent/US8637702B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102548551A (zh) | 2012-07-04 |
| CA2773210C (en) | 2017-01-03 |
| JP2013508349A (ja) | 2013-03-07 |
| KR101687644B1 (ko) | 2016-12-19 |
| US20120203014A1 (en) | 2012-08-09 |
| CA2773210A1 (en) | 2011-04-28 |
| US8637702B2 (en) | 2014-01-28 |
| EP2490682A1 (en) | 2012-08-29 |
| IT1396915B1 (it) | 2012-12-20 |
| ITMI20091837A1 (it) | 2011-04-23 |
| JP5746196B2 (ja) | 2015-07-08 |
| KR20120083356A (ko) | 2012-07-25 |
| BR112012008780A2 (pt) | 2020-12-01 |
| WO2011048514A1 (en) | 2011-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| IN2012DN03387A (enExample) | ||
| ECSP11011453A (es) | Tratamiento de trastornos cognitivos con determinados receptores de ácido nicotínico alfa-7 en combinación con inhibidores de acetilcolinesterasa | |
| MX2009003372A (es) | Formas de dosificacion de pelicula no mucoadhesiva. | |
| NZ593754A (en) | Dpp-iv inhibitors for treatment of diabetes in paediatric patients | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| CL2011001178A1 (es) | Uso de (r)-7-cloro-niquinuclidin-3-1l)senzo[b]tiofen0-2-carboxamida o una sal de la misma o una composicion farmaceutica que la comprende para preparar un medicamento util para mejorar la cognicion en un paciente que sufre de alzheimer o esquizofrenia. | |
| MX2011011083A (es) | Compuestos heterociclicos como inhibidores de mek. | |
| EA200971086A1 (ru) | Фармацевтические композиции и способ лечения шизофрении | |
| TW200616608A (en) | Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients | |
| UA104148C2 (ru) | [4-(5-аминометил-2-фторфенил)-пиперидин-1-ил]-[7-фтор-1-(2-метоксиэтил)-4-трифторметокси-1h-индол-3-ил]-метанон как ингибитор триптазы тучных клеток | |
| PH12012501358A1 (en) | Treatment method | |
| BR112014010729A2 (pt) | métodos para tratamento de ataques de gota | |
| TNSN08506A1 (en) | Substituted carboxamides | |
| MX341660B (es) | Agonista del receptor de ghrelina para el tratamiento de caquexia. | |
| MX357507B (es) | Metodos para tratar hiperucemia en pacientes con gota utilizando halofenato o acido halofenico y un segundo agente de reduccion de urato. | |
| DE602006017728D1 (de) | Krebsbehandlung mittels fts und 2-deoxyglucose | |
| RU2011123367A (ru) | Способ лечения или профилактики тромбоза с использованием этексилата дабигатрана или его соли с улучшенной эффективностью по сравнению со стандартным лечением варфарином | |
| DE602007014193D1 (de) | Behandlung psychiatrischer patienten mit schlafstörungen und/oder übermässiger tagesschläfrigkeit mit paliperidon | |
| PT2480232E (pt) | [4-(5-aminometil-fenil)-piperidin-1-il]-1h-indol-3-il]- metanonas dissubstituídas | |
| PH12014502282A1 (en) | Method for treating hyperuricemia in patients with gout using halofenate or halofenic acid and an anti-inflammatory agent | |
| GB0405381D0 (en) | A method and means for treating heart failure | |
| MX2008011321A (es) | Composicion farmaceutica para el uso en el tratamiento de infecciones de transmision sexual. | |
| WO2007144889A3 (en) | Treatment of neurofibromatosis | |
| MX2010006310A (es) | O-desmetil-venlafaxina para el tratamiento de transtorno depresivo mayor. |